Nucleic Acid Isolation And Purification Market Size Projected to Reach $14.99 billion by 2034 | 10.08%

The global nucleic acid isolation and purification market size reached USD 6.33 billion in 2025 and is anticipated to grow from USD 6.95 billion in 2026 to USD 14.99 billion by 2034, expanding at a CAGR of 10.08% over the forecast period from 2026 to 2034.

Nucleic acid isolation and purification is an initial step in the study of molecular biology and recombinant DNA technique. It allows the processing of several samples in less time, minimizes loss of nucleic acid degradation, and improves productivity and effectiveness in the laboratory.  

The biotechnology and pharmaceutical segment is expected to register the fastest growth during the forecast period. DNA or RNA isolation and purification are essential steps of drug discovery, target identification, and phase testing during drug development. Several pharmaceutical companies are making substantial investments in R&D activities for drug discovery projects, further driving the segment growths. 

Rising adoption of CRISPR technology to identify and validate novel therapeutics provides an impetus to the market growth. The introduction of genome editing techniques and reduction in R&D costs accelerates the process of drug development, further driving the adoption of nucleic acid and extraction kits in the pharmaceutical and biotech companies. 

Key Highlights

• The global nucleic acid isolation and purification market size reached USD 6.33 billion in 2025 and is anticipated to grow from USD 6.95 billion in 2026 to USD 14.99 billion by 2034, expanding at a CAGR of 10.08% over the forecast period on account of increasing public-private funding for life science research, technological progressions, and growing automation.
• The kits segment is predicted to hold the largest market share for their low cost and ease of use in gene sequencing, molecular diagnostics, and gene cloning.
• In 2026, the diagnostics segment held the largest market share on account of growing awareness about genomic diagnostics and rising efficiency of genomic sequencing in the diagnosis of diseases.
• North America dominates the nucleic acid isolation and purification market on account of rising R&D expenditure by biotechnology and pharmaceutical firms, technological advancements, and government support.

Market Segments

1. By Product
   1. Kits and Reagents
   2. Instruments
2. By Method
   1. Column-Based Isolation and Purification
   2. Reagent-Based Isolation and Purification
   3. Magnetic Bead-Based Isolation and Purification
3. By Type
   1. Plasmid DNA Isolation and Purification
   2. Total RNA Isolation and Purification
   3. Genomic DNA Isolation and Purification
4. By Application
   1. Diagnostics
   2. Precision Medicine
   3. Drug Discovery and Development
   4. Agriculture and Animal Research
5. By End-User
   1. Hospital and Clinics
   2. Pharmaceutical and Biotechnology
   3. Research Centers and Government Institutes